The percentage of CD8+ T cells in melanoma TME was significantly lower in younger patients under the age of 66 years, which correlated with increased numbers in tumor-infiltrating FOXP3 regulatory T cells, indicating that tumors in young patients are accommodated with a more vital immunosuppressive environment with higher frequencies of potent Tregs. This evidence concerns the gene FOXP3 and melanoma.